Trademark: 90733679
Word
MAB2
Status
Registered
Status Code
700
Status Date
Tuesday, August 15, 2023
Serial Number
90733679
Registration Number
7135330
Registration Date
Tuesday, August 15, 2023
Mark Type
5000
Filing Date
Tuesday, May 25, 2021
Published for Opposition
Tuesday, May 30, 2023

Trademark Owner History
F-STAR THERAPEUTICS LIMITED - Original Registrant
F-star Biotechnology Limited - Original Applicant

Classifications
5 Pharmaceutical, biopharmaceutical and medical preparations, agents and substances, all containing or being monoclonal antibodies for medical purposes, and all for treatment of cancer, oncological diseases and disorders, infectious diseases and disorders, inflammation and diseases, disorders and conditions associated with inflammation, inflammatory diseases and disorders, and neurological diseases and disorders; bispecific and multispecific monoclonal antibodies for medical use; products in the nature of pharmaceutical preparations and medicines containing multispecific, in particular bispecific, monoclonal antibodies for use in medicine; diagnostic preparations, agents and substances, all containing or being monoclonal antibodies, for medical purposes
1 Biological preparations containing monoclonal antibodies for scientific, industrial, and research use; bispecific and multispecific monoclonal antibodies, and fragments thereof, for scientific, industrial, and research use
42 Scientific and technological services, namely scientific research and design in the field of immunoglobulins and antibodies for medical purposes; scientific research, namely industrial analysis and research services, in the field of immunoglobulins and antibodies for medical purposes; pharmaceutical, scientific and biopharmaceutical research and development; medical research and development in the field of immunoglobulins and antibodies for medical purposes; drug discovery services; research relating to medicines; research and development of medicines; development of pharmaceutical and biopharmaceutical preparations and medicines; all of the foregoing involving monoclonal antibodies
The mark consists of the lower case letter "M" followed by an upper case letter "A" followed by a lower case letter "B" with a superscript "2" following the "B".
MAB TWO

Trademark Events
Aug 15, 2023
Notice Of Registration Confirmation Emailed
Aug 15, 2023
Registered-Principal Register
May 30, 2023
Official Gazette Publication Confirmation E-Mailed
May 30, 2023
Published For Opposition
May 10, 2023
Notification Of Notice Of Publication E-Mailed
Apr 27, 2023
Approved For Pub - Principal Register
Apr 27, 2023
Examiner's Amendment Entered
Apr 27, 2023
Notification Of Examiners Amendment E-Mailed
Apr 27, 2023
Examiners Amendment E-Mailed
Apr 27, 2023
Examiners Amendment -Written
Mar 21, 2023
Teas/Email Correspondence Entered
Mar 20, 2023
Correspondence Received In Law Office
Mar 20, 2023
Teas Response To Office Action Received
Sep 20, 2022
Notification Of Non-Final Action E-Mailed
Sep 20, 2022
Non-Final Action E-Mailed
Sep 20, 2022
Non-Final Action Written
Aug 16, 2022
Assigned To Examiner
Jul 28, 2022
Teas/Email Correspondence Entered
Jul 28, 2022
Correspondence Received In Law Office
Jul 28, 2022
Teas Response To Office Action Received
May 19, 2022
Automatic Update Of Assignment Of Ownership
Feb 8, 2022
Notification Of Non-Final Action E-Mailed
Feb 8, 2022
Non-Final Action E-Mailed
Feb 8, 2022
Non-Final Action Written
Feb 7, 2022
Assigned To Examiner
Aug 20, 2021
New Application Office Supplied Data Entered
May 28, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24